These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 22264780)
1. Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus. Tavira B; Coto E; Torres A; Díaz-Corte C; Díaz-Molina B; Ortega F; Arias M; Díaz JM; Selgas R; López-Larrea C; Ruiz-Ortega M; Ortiz A; González E; Campistol JM; Alvarez V; Mol Genet Metab; 2012 Mar; 105(3):525-7. PubMed ID: 22264780 [TBL] [Abstract][Full Text] [Related]
2. Association between E23K variant in KCNJ11 gene and new-onset diabetes after liver transplantation. Parvizi Z; Azarpira N; Kohan L; Darai M; Kazemi K; Parvizi MM Mol Biol Rep; 2014 Sep; 41(9):6063-9. PubMed ID: 24996284 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patients. Tavira B; Gómez J; Díaz-Corte C; Llobet L; Ruiz-Pesini E; Ortega F; Coto E Gene; 2014 Mar; 538(1):195-8. PubMed ID: 24445060 [TBL] [Abstract][Full Text] [Related]
4. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients. Tavira B; Coto E; Díaz-Corte C; Ortega F; Arias M; Torres A; Díaz JM; Selgas R; López-Larrea C; Campistol JM; Ruiz-Ortega M; Alvarez V; Clin Transplant; 2011; 25(3):E284-91. PubMed ID: 21355884 [TBL] [Abstract][Full Text] [Related]
5. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus. Elens L; Sombogaard F; Hesselink DA; van Schaik RH; van Gelder T Pharmacogenet Genomics; 2013 Dec; 23(12):649-57. PubMed ID: 24113216 [TBL] [Abstract][Full Text] [Related]
6. Polymorphism E23K (rs5219) in the KCNJ11 gene in Euro-Brazilian subjects with type 1 and 2 diabetes. Souza SW; Alcazar LP; Arakaki PA; Santos-Weiss IC; Alberton D; Picheth G; Rego FG Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28387875 [TBL] [Abstract][Full Text] [Related]
7. Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimus. Kurzawski M; Dziewanowski K; Łapczuk J; Wajda A; Droździk M Eur J Clin Pharmacol; 2012 Dec; 68(12):1587-94. PubMed ID: 22569928 [TBL] [Abstract][Full Text] [Related]
8. KCNJ11 and KCNQ1 Gene Polymorphisms Are Not Associated with Post-Transplant Diabetes Mellitus in Kidney Allograft Recipients Treated with Tacrolimus. Dabrowska-Zamojcin E; Tarnowski M; Szydlowski M; Romanowski M; Dziedziejko V; Safranow K; Domanski L; Pawlik A Folia Biol (Praha); 2017; 63(3):115-119. PubMed ID: 28805561 [TBL] [Abstract][Full Text] [Related]
9. The E23K and A190A variations of the KCNJ11 gene are associated with early-onset type 2 diabetes and blood pressure in the Chinese population. Zhuang L; Zhao Y; Zhao W; Li M; Yu M; Lu M; Zhang R; Ge X; Zheng T; Li C; Yin J; Yin J; Bao Y; Liu L; Jia W; Liu Y Mol Cell Biochem; 2015 Jun; 404(1-2):133-41. PubMed ID: 25725792 [TBL] [Abstract][Full Text] [Related]
10. Association of KCNJ11 rs5219 gene polymorphism with type 2 diabetes mellitus in a population of Syria: a case-control study. Makhzoom O; Kabalan Y; Al-Quobaili F BMC Med Genet; 2019 Jun; 20(1):107. PubMed ID: 31195986 [TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in KCNJ11 (E23K, rs5219) and SDF-1β (G801A, rs1801157) genes are associated with the risk of type 2 diabetes mellitus. Rizvi S; Raza ST; Mahdi F; Singh SP; Rajput M; Rahman Q Br J Biomed Sci; 2018 Jul; 75(3):139-144. PubMed ID: 29893194 [TBL] [Abstract][Full Text] [Related]
12. Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus. Shaat N; Ekelund M; Lernmark A; Ivarsson S; Almgren P; Berntorp K; Groop L Diabetologia; 2005 Dec; 48(12):2544-51. PubMed ID: 16320083 [TBL] [Abstract][Full Text] [Related]
13. Lack of genetic susceptibility of KCNJ11 E23K polymorphism with risk of type 2 diabetes in an Iranian population. Keshavarz P; Habibipour R; Ghasemi M; Kazemnezhad E; Alizadeh M; Omami MH Endocr Res; 2014; 39(3):120-5. PubMed ID: 24460047 [TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Florez JC; Jablonski KA; Kahn SE; Franks PW; Dabelea D; Hamman RF; Knowler WC; Nathan DM; Altshuler D Diabetes; 2007 Feb; 56(2):531-6. PubMed ID: 17259403 [TBL] [Abstract][Full Text] [Related]
15. KCNJ11 E23K variant is associated with the therapeutic effect of sulphonylureas in Chinese type 2 diabetic patients. Li Q; Chen M; Zhang R; Jiang F; Wang J; Zhou J; Bao Y; Hu C; Jia W Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):748-54. PubMed ID: 25115353 [TBL] [Abstract][Full Text] [Related]
16. Association of transcription factor 7-like 2 (TCF7L2) gene polymorphism with posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus. Kurzawski M; Dziewanowski K; Kędzierska K; Wajda A; Lapczuk J; Droździk M Pharmacol Rep; 2011; 63(3):826-33. PubMed ID: 21857094 [TBL] [Abstract][Full Text] [Related]
17. CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients. Shi D; Xie T; Deng J; Niu P; Wu W Eur J Clin Pharmacol; 2018 Jun; 74(6):723-729. PubMed ID: 29546446 [TBL] [Abstract][Full Text] [Related]
18. Effects of single nucleotide polymorphisms in K(ATP) channel genes on type 2 diabetes in a Turkish population. Gonen MS; Arikoglu H; Erkoc Kaya D; Ozdemir H; Ipekci SH; Arslan A; Kayis SA; Gogebakan B Arch Med Res; 2012 May; 43(4):317-23. PubMed ID: 22704848 [TBL] [Abstract][Full Text] [Related]
19. Population specific impact of genetic variants in KCNJ11 gene to type 2 diabetes: a case-control and meta-analysis study. Phani NM; Guddattu V; Bellampalli R; Seenappa V; Adhikari P; Nagri SK; D Souza SC; Mundyat GP; Satyamoorthy K; Rai PS PLoS One; 2014; 9(9):e107021. PubMed ID: 25247988 [TBL] [Abstract][Full Text] [Related]
20. Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients. Chen QJ; Li J; Zuo SR; Zhang YP; Jia SJ; Yuan H; Liu SK; Cheng K; Ming YZ; Zuo XC; Luo AJ; Xie WZ; Cai JJ; Yang M; Wang JL Ren Fail; 2015 May; 37(4):601-6. PubMed ID: 25644968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]